StockData
Incyte Corp logo

Incyte Corp (INCY) stock

INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3086% above fair value
$114.63−1.25 (-1.07%)

Close on Nov 20, 2026Market cap $23.36BP/E 61.0Yield –

Incyte net income

Net income is the profit left for shareholders after every expense, interest and tax.

Incyte's net income for the twelve months ending Sep 30, 2026 was $403.41M, down 66.1% year over year. For fiscal 2025 it was $1.29B, up 3845.0% from the year before. The highest annual figure on record is $1.29B in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.29B+3845.0%
FY2024Dec 31, 2024$32.62M-94.5%
FY2023Dec 31, 2023$597.60M+75.4%
FY2022Dec 31, 2022$340.66M-64.1%
FY2021Dec 31, 2021$948.58M–
FY2020Dec 31, 2020-$295.70M-166.2%
FY2019Dec 31, 2019$446.91M+308.2%
FY2018Dec 31, 2018$109.49M–
FY2017Dec 31, 2017-$313.14M-400.5%
FY2016Dec 31, 2016$104.22M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$784.80M-285.0%
Q2 FY2026Jun 30, 2026$585.61M+44.6%
Q1 FY2026Mar 31, 2026$303.33M+91.7%
Q4 FY2025Dec 31, 2025$299.28M+48.7%
Q3 FY2025Sep 30, 2025$424.17M+298.4%
Q2 FY2025Jun 30, 2025$405.00M–
Q1 FY2025Mar 31, 2025$158.20M-6.7%
Q4 FY2024Dec 31, 2024$201.21M+0.1%
Q3 FY2024Sep 30, 2024$106.46M-37.8%
Q2 FY2024Jun 30, 2024-$444.60M-318.4%
Q1 FY2024Mar 31, 2024$169.55M+681.2%
Q4 FY2023Dec 31, 2023$201.08M+606.5%
Q3 FY2023Sep 30, 2023$171.27M+51.9%
Q2 FY2023Jun 30, 2023$203.55M+26.1%
Q1 FY2023Mar 31, 2023$21.70M-42.9%
Q4 FY2022Dec 31, 2022$28.46M-95.0%
Q3 FY2022Sep 30, 2022$112.78M-37.9%
Q2 FY2022Jun 30, 2022$161.43M+8.0%
Q1 FY2022Mar 31, 2022$37.99M-29.0%
Q4 FY2021Dec 31, 2021$563.85M+276.3%
Q3 FY2021Sep 30, 2021$181.74M–
Q2 FY2021Jun 30, 2021$149.46M-48.5%
Q1 FY2021Mar 31, 2021$53.54M–
Q4 FY2020Dec 31, 2020$149.85M+35.0%
Q3 FY2020Sep 30, 2020-$15.20M-111.9%
Q2 FY2020Jun 30, 2020$290.30M+175.6%
Q1 FY2020Mar 31, 2020-$720.64M-804.4%
Q4 FY2019Dec 31, 2019$111.01M+60.7%
Q3 FY2019Sep 30, 2019$128.27M+339.6%
Q2 FY2019Jun 30, 2019$105.32M+101.0%
Q1 FY2019Mar 31, 2019$102.31M–
Q4 FY2018Dec 31, 2018$69.06M–
Q3 FY2018Sep 30, 2018$29.18M-19.1%
Q2 FY2018Jun 30, 2018$52.39M–
Q1 FY2018Mar 31, 2018-$41.14M–
Q4 FY2017Dec 31, 2017-$149.63M–
Q3 FY2017Sep 30, 2017$36.05M–
Q2 FY2017Jun 30, 2017-$12.48M–
Q1 FY2017Mar 31, 2017-$187.08M–

More Incyte figures

See a number that looks wrong?